FindTrial
Sign In

Comparison of anterior fibromuscular stroma sparing and conventional holmium laser enucleation for prostate gland hyperplasia

Comparison between anterior fibromuscular stroma sparing and conventional holmium laser enucleation for prostate gland hyperplasia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009320
Enrollment
Unknown
Registered
2016-10-06
Start date
2016-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperplasia

Interventions

AFMS-group:nterior fibromuscular stroma sparing HoLEP
HoLEP-group:HoLEP surgery

Sponsors

The Second Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
51 Years to 96 Years

Inclusion criteria

Inclusion criteria: Patient with prostate gland hyperplasia

Exclusion criteria

Exclusion criteria: Patients with severe pulmonary disease or heart disease, bladder calculus, neurogenic bladder dysfunction, bladder cancer, previous prostate surgery, prostate cancer, urethral stricture or coagulopathy were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Qmax;IPSS score;QOL score;Urinary incontinence score;—

Countries

China

Contacts

Public ContactMingzhen Yuan

The Second Hospital of Shandong University

yuanmingzhen2005@126.com+86 18253132651

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026